Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

  • Serum sialyl lewis X-i antigen levels in non-small cell lung cancer: correlation with distant metastasis and survival.
    H Satoh, H Ishikawa, H Kamma, Y T Yamashita, H Takahashi, M Ohtsuka and S Hasegawa
    Clin Cancer Res April 1 1997 3 (4) 495-499;

  • Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.
    D J Lee, W M Koch, G Yoo, M Lango, A Reed, J Califano, J A Brennan, W H Westra, M Zahurak and D Sidransky
    Clin Cancer Res April 1 1997 3 (4) 501-505;

  • Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    J H Li, P Li, H Klamut and F F Liu
    Clin Cancer Res April 1 1997 3 (4) 507-514;

  • Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    V Rusch, D Klimstra, E Venkatraman, P W Pisters, J Langenfeld and E Dmitrovsky
    Clin Cancer Res April 1 1997 3 (4) 515-522;

  • Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    K Watanabe, K Sato, W Biernat, O Tachibana, K von Ammon, N Ogata, Y Yonekawa, P Kleihues and H Ohgaki
    Clin Cancer Res April 1 1997 3 (4) 523-530;

  • Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    I Osman, H I Scher, Z F Zhang, I Pellicer, R Hamza, S Eissa, H Khaled and C Cordon-Cardo
    Clin Cancer Res April 1 1997 3 (4) 531-536;

  • A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
    G K Schwartz, D Ward, L Saltz, E S Casper, T Spiess, E Mullen, J Woodworth, R Venuti, P Zervos, A M Storniolo and D P Kelsen
    Clin Cancer Res April 1 1997 3 (4) 537-543;

  • Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.
    C C Chen, B Meadows, J Regis, G Kalafsky, T Fojo, J A Carrasquillo and S E Bates
    Clin Cancer Res April 1 1997 3 (4) 545-552;

  • Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.
    M Chazal, S Cheradame, J L Formento, M Francoual, P Formento, M C Etienne, E François, H Richelme, M Mousseau, C Letoublon, D Pezet, H Cure, J F Seitz and G Milano
    Clin Cancer Res April 1 1997 3 (4) 553-557;

  • Cathepsin D and dynamic magnetic resonance imaging gadolinium enhancement in malignant and benign breast lesions.
    P C Stomper, J S Winston, S Herman, D L Klippenstein and L E Blumenson
    Clin Cancer Res April 1 1997 3 (4) 559-563;

  • Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.
    K Margolin, M Atkins, J Sparano, J Sosman, G Weiss, M Lotze, J Doroshow, J Mier, K O'Boyle, R Fisher, E Campbell, J Rubin, D Federighi and S Bursten
    Clin Cancer Res April 1 1997 3 (4) 565-572;

  • IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.
    B Seliger, S Hammers, A Höhne, R Zeidler, A Knuth, C D Gerharz and C Huber
    Clin Cancer Res April 1 1997 3 (4) 573-578;

  • Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.
    I Faraoni, M Turriziani, G Masci, L De Vecchis, J W Shay, E Bonmassar and G Graziani
    Clin Cancer Res April 1 1997 3 (4) 579-585;

  • Patterns of DNA ploidy and S-phase fraction associated with breast cancer survival in blacks and whites.
    Y H Shiao, V W Chen, H P Lehmann, X C Wu and P Correa
    Clin Cancer Res April 1 1997 3 (4) 587-592;

  • Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
    A Makris, T J Powles, M Dowsett, C K Osborne, P A Trott, I N Fernando, S E Ashley, M G Ormerod, J C Titley, R K Gregory and D C Allred
    Clin Cancer Res April 1 1997 3 (4) 593-600;

  • Lack of prognostic significance of histological grade in node-negative invasive breast carcinoma.
    M Younes and R Laucirica
    Clin Cancer Res April 1 1997 3 (4) 601-604;

  • Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
    H Singhal, D S Bautista, K S Tonkin, F P O'Malley, A B Tuck, A F Chambers and J F Harris
    Clin Cancer Res April 1 1997 3 (4) 605-611;

  • Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume.
    K Fujikawa, M Sasaki, Y Arai, H Yamabe, O Ogawa and O Yoshida
    Clin Cancer Res April 1 1997 3 (4) 613-618;

  • Clinical implications of telomerase activity levels in acute leukemia.
    J H Ohyashiki, K Ohyashiki, H Iwama, S Hayashi, K Toyama and J W Shay
    Clin Cancer Res April 1 1997 3 (4) 619-625;

  • Telomerase activity in normal and neoplastic breast.
    J l Tsao, Y Zhao, J Lukas, X Yang, A Shah, M Press and D Shibata
    Clin Cancer Res April 1 1997 3 (4) 627-631;

  • In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Y Fujimiya, Y Suzuki, R Katakura, T Miyagi, T Yamaguchi, T Yoshimoto and T Ebina
    Clin Cancer Res April 1 1997 3 (4) 633-643;

Back to top
PreviousNext
April 1997
Volume 3, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)

Sign up for alerts

Advertisement
  • Most Cited
  • Most Read
Loading
  • Immune Checkpoint Blockade Requires Macrophage CXCL9/CXCL10
  • PDAC and GATA6 Expression
  • Characterization of Glioblastoma Patient-Derived Xenografts
  • Guadecitabine and Carboplatin in Ovarian Cancer
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement